MIKEL
EGUIGUREN BASTIDA
Investigador hasta 2022
Hospital Universitario de Donostia
San Sebastián, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Donostia (2)
2020
-
Age, Gleason Score, and PSA are important prognostic factors for survival in metastatic castration-resistant prostate cancer. Results of The Uroncor Group (Uro-Oncological Tumors) of the Spanish Society of Radiation Oncology (SEOR)
Clinical and Translational Oncology, Vol. 22, Núm. 8, pp. 1378-1389
2015
-
Could preoperative short-course radiotherapy be the treatment of choice for localized advanced rectal carcinoma?
Reports of Practical Oncology and Radiotherapy, Vol. 20, Núm. 1, pp. 1-11